Primary contact

Univercells is a technology company offering novel biomanufacturing platforms, aimed at increasing the availability and affordability of biologics — recombinant proteins and vaccines — for all. Univercells designs innovative production processes to significantly decrease the size of the necessary equipment and facility, for a lower capital and operational cost. The company's process intensification and integration technology entails smaller footprint and unit cost while offering flexible capabilities, from small to large batches. Deployment of affordable production units enables "​in-country, for-country" biologics production, creating value for manufacturers and healthcare systems with cost efficiency and local supply while increasing patients' access to healthcare.
Primary contact

Funding 💰

Select investors Takeda Ventures, Bill & Melinda Gates Foundation
Last update: May 14, 2018